Therefore, some invasive procedures may be used for conversion to Eisenmenger physiology with the aim of decompressing the right ventricle
📌 3 Maddede Bu Makale
🎯
Amaç & Hipotez:Despite advances in the medical treatment of children with pulmonary arterial hypertension that have resulted in improved health quality and life expectancy, the progression of the disease is still the main problem for some patients.
📊
Temel Bulgular & Veri:Because of this undesirable condition, the search for new treatment strategies continues for pediatric cardiologists.
💡
Sonuç & Katkı:Therefore, some invasive procedures may be used for conversion to Eisenmenger physiology with the aim of decompressing the right ventricle
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri
Abstract
Despite advances in the medical treatment of children with pulmonary arterial hypertension that have resulted in improved health quality and life expectancy, the progression of the disease is still the main problem for some patients. Because of this undesirable condition, the search for new treatment strategies continues for pediatric cardiologists. At this point, the Eisenmenger physiology is the main target because of the long-life expectancy and more stable hemodynamics of patients with Eisenmenger syndrome. Therefore, some invasive procedures may be used for conversion to Eisenmenger physiology with the aim of decompressing the right ventricle
🔖
Bu Makaleye Atıf Yap
KULA, S., ATASAYAN, V. (2015). Surgical and transcatheter management alternatives in refractory pulmonary hypertension: Potts shunt. The Anatolian Journal of Cardiology, Cilt: 15 - Sayı: 10, 843–847. https://ajindex.com/articles/366769
Garbarz E, Iung B, Cormier B, Vahania A. Echocardiographic Criteria in Selection of Patients for Percutaneous Mitral Commissurotomy. Echocardiography 1999; 16: 711-21. [CrossRef] Address for Correspondence: Dr. Muhammad Tariq Farman, Jinnah Medical College Hospital C-45, Block-2, KAECHS, Karachi-Pakistan Phore: +923002214733 Steg PG, James S, Harrington RA, Ardissino D, Becker RC, Cannon CP, et al.; PLATO Study Group. Ticagrelor versus clopidogrel in patients with ST-elevation acute coronary syndromes intended for reperfusion with primary percutane- ous coronary intervention: A Platelet Inhibition and Patient Outcomes (PLATO) trial subgroup analysis. Circulation 20